No vaccine against HIV yet-are we not perfectly equipped?
2006

Challenges in Developing an HIV Vaccine

publication Evidence: moderate

Author Information

Author(s): Mahender Singh

Primary Institution: Thomas Jefferson University

Hypothesis

Is the replication machinery of HIV so unique that it can easily evade therapeutic and preventive approaches?

Conclusion

The unique biology of HIV replication and its high mutation rate make it extremely challenging to develop an effective vaccine against AIDS.

Supporting Evidence

  • The high genetic variability of HIV complicates vaccine development.
  • Current vaccine strategies induce CTL in nonhuman primate models but fail in early clinical trials.
  • Traditional vaccination approaches have not been effective against HIV-1.

Takeaway

Scientists are trying to create a vaccine for HIV, but the virus changes so quickly that it's really hard to make one that works.

Methodology

The article reviews various vaccine strategies and discusses the unique challenges posed by HIV's biology.

Limitations

The article does not provide exhaustive coverage of all research articles on HIV vaccine development.

Digital Object Identifier (DOI)

10.1186/1743-422X-3-60

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication